Lee's Pharmaceutical Holdings Limited
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
2/10
|
52.9 | 35.42 | 49.36% | 23.83 | +121.95% |
| P/S |
|
0.8388 | 7.59 | -88.95% |
|
|
| P/BV |
|
0.4505 | 3.68 | -87.77% |
|
|
| P/FCF |
|
-17.32 | 55.3 | -131.33% |
|
|
| Ev/Ebitda |
|
3.67 | 2.91 | 26.21% |
|
|
| Ev/S |
|
0.8594 | 23.72 | -96.38% |
|
|
| Ev/FCF |
|
-18.24 | 63.78 | -128.59% |
|
|
| E/P |
|
0.0194 | 0.0326 | -40.55% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
6/10
|
18.41 | -11.9 | -254.69% | 47.61 | -61.33% |
| ROE |
|
0.8427 | 5.19 | -83.75% |
|
|
| ROA |
|
0.5887 | 3.47 | -83.03% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
1.59 | -11.49 | -113.84% |
|
|
| ROCE |
|
0 | 6.04 | -100% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
9/10
|
0.7203 | 0.7755 | -7.12% | 0.8035 | -10.36% |
| Nеt Debt/Ebitda |
|
0.0958 | 0.0127 | 652.73% |
|
|
| Debt/Ratio |
|
0.0566 | 0.1229 | -53.96% |
|
|
| Debt/Equity |
|
0.3024 | 0.802 | -62.3% |
|
|
| Debt/Net Income |
|
9.79 | 1.76 | 457.12% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
4.63/10
|
1.85 | 5.7 | -67.54% | 2.16 | -14.21% |
| Number of years of dividend growth |
|
0 | 1.13 | -100% | ||
| DSI |
|
0.7143 | 0.5838 | 22.35% |
|
|
| Average dividend growth |
|
-13.5 | 3.2 | -521.49% |
|
|
| Average percentage for 5 years |
|
2.16 | 4.95 | -56.46% |
|
|
| Average percentage for payments |
|
26.43 | 23.96 | 10.31% |
|
|
| Difference from average difference in sector |
|
-3.85 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-13.61 | 28.69 | -147.44% | ||
| Growth impulse Ebitda in 5 years |
|
-65.21 | -40.52 | 60.93% | ||
| Growth impulse Net Income in 5 years |
|
-86.7 | 94.84 | -191.42% | ||
| Growth impulse FCF in 5 years |
|
-216.55 | 91.41 | -336.9% | ||
| Growth impulse EPS in 5 years |
|
-86.85 | -118.14 | -26.49% |
IP Score
4.1/10
